Table 4.
Multivariate linear regression model for BMI change.
| Variable | Beta | 95% CI | p-Value |
|---|---|---|---|
| Age (years) | −0.02 | −0.04, 0.01 | 0.16 |
| Sex: male vs. female | 0.31 | −0.19, 0.80 | 0.22 |
| Baseline HbA1c (%) | −0.06 | −0.23, 0.11 | 0.50 |
| Baseline BMI (kg/m2) | −0.05 | −0.11, 0.01 | 0.085 |
| T2DM duration | −0.01 | −0.04, 0.01 | 0.24 |
| Dose of oral semaglutide (mg) | −0.03 | −0.09, 0.04 | 0.42 |
| Last follow-up (months) | −0.07 | −0.16, 0.02 | 0.11 |
| Monotherapy vs. association | 0.02 | −1.23, 1.28 | 0.97 |
| SWITCH vs. ADD-ON group | 0.53 | −0.03, 1.08 | 0.06 |
| Insulin (yes vs. no) | 0.55 | −0.07, 1.17 | 0.08 |
| SGLT2 (yes vs. no) | −0.17 | −0.70, 0.36 | 0.52 |
| R2 = 0.149; AIC = 407 |